In deliveryUnited KingdomGoodsFramework agreement£146,579,216
Branded and Biosimilar Ophthalmology
- Published
- Published 6 August 2025
- Deadline
- Closed 5 September 2025
Overview
Supply of Branded and Biosimilar Ophthalmology to NHS Scotland.
Key details
- Country
- United Kingdom
- Status
- In delivery
- Category
- Goods
- Estimated value
- £146,579,216
- Procedure
- Open
- Contract type
- Framework agreement
- Published
- 6 August 2025
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- £20,671,084
- Award date
- 30 October 2025
- Contract period
- — → 25 October 2026
- Bayer Plc
- Biogen Idec Ltd
- Celltrion Healthcare United Kingdom Limited
- MD Biologics
- Mercury Pharmaceuticals Limited
- Sandoz
- Teva UK Ltd
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract
24 November 2025
View notice ↗Contract Notice
6 August 2025
View notice ↗
Contracting authority
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
BuyerEdinburgh, United Kingdom
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.